Please login to the form below

Not currently logged in

Ferring collaborates on novel IBD drug development

Project in partnership with Paris-based Institut Pasteur

Ferring HQ 

Ferring Pharmaceuticals and non-profit biomedical research centre the Institut Pasteur are to collaborate on drug development for patients with inflammatory bowel disease (IBD).

The collaboration will aim to identify and develop bacteriophages, viruses that infect bacteria, which were commonly used prior to the development of antibiotics. The use of bacteriophages has again come to the forefront of the field due to concerns of increased bacterial resistance due to overuse of antibiotics.

Per Falk, executive VP and chief scientific officer at Ferring Pharmaceuticals, commented: “Data generated in our collaboration with the Institut Pasteur and the fact that many patients with IBD are colonised by bacteria known to cause aggressive infections, show us that bacteriophages have an important role to play in the treatment of IBD.

“A dedicated programme will now start to develop a Ferring medicine from these research findings.”

Following a recent finding linking infection to the onset of Crohn's Disease, a chronic IBD condition, Ferring and the Paris-based Institut Pasteur's new programme will aim to test the feasibility and efficacy of these bacteriophages in controlled clinical trials.

Isabelle Buckle, executive VP, technology transfer and industrial partnership at the Insistut Pasteur, added: “It is very exciting to see bacteriophages, discovered many years ago, return to bring a real advantage to patients today.

“The collaboration with Ferring is a very good example of a successful academic and industry partnership. We believe that IBD patients will benefit from it.”

Article by
Kirstie Pickering

20th April 2015

From: Research



Featured jobs

Subscribe to our email news alerts


Add my company

Established in 2002, Star is a full service outsourcing and resourcing company that works with the best people and opportunities...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...